Structure-activity relationship studies and in vitro and in vivo anticancer activity of novel 3-aroyl-1,4-diarylpyrroles against solid tumors and hematological malignancies

Michela Puxeddu, Hongliang Shen, Ruoli Bai, Antonio Coluccia, Marianna Nalli, Carmela Mazzoccoli, Eleonora Da Pozzo, Chiara Cavallini, Claudia Martini, Viviana Orlando, Stefano Biagioni, Cristina Mazzoni, Addolorata Maria Luce Coluccia, Ernest Hamel, Te Liu, Romano Silvestri, Giuseppe La Regina

Research output: Contribution to journalArticle

Abstract

Novel 3-aroyl-1,4-diarylpyrrole derivatives were synthesized to explore structure-activity relationships at the phenyls at positions 1 and 4 of the pyrrole. The presence of amino phenyl rings at positions 1 and 4 of the pyrrole ring were found to be a crucial requirement for potent antitumor activity. Several compounds strongly inhibited tubulin assembly through binding to the colchicine site. Compounds 42, 44, 48, 62 and 69 showed antitumor activity with low nanomolar IC50 values in several cancer cell lines. Compound 48 was generally more effective as an inhibitor of glioblastoma, colorectal and urinary bladder cancer cell lines; 69 consistently inhibited CML cell lines and demonstrated superiority in nilotinib and imatinib resistant LAMA84-R and KBM5-T315I cells. In animal models, compound 48 exhibited significant inhibition of the growth of T24 bladder carcinoma and ES-2 ovarian clear cell carcinoma tumors. Compounds 48 and 69 represent robust lead compounds for the design of new broad-spectrum anticancer agents active in different types of solid and hematological tumors.

Original languageEnglish
Pages (from-to)111828
JournalEuropean Journal of Medicinal Chemistry
DOIs
Publication statusE-pub ahead of print - Nov 2 2019

Fingerprint

Hematologic Neoplasms
Structure-Activity Relationship
Tumors
Pyrroles
Cells
Cell Line
Carcinoma
Neoplasms
Colchicine
Tubulin
Glioblastoma
Lead compounds
Urinary Bladder Neoplasms
Emitter coupled logic circuits
Antineoplastic Agents
Inhibitory Concentration 50
Urinary Bladder
Animal Models
Animals
Growth

Cite this

Structure-activity relationship studies and in vitro and in vivo anticancer activity of novel 3-aroyl-1,4-diarylpyrroles against solid tumors and hematological malignancies. / Puxeddu, Michela; Shen, Hongliang; Bai, Ruoli; Coluccia, Antonio; Nalli, Marianna; Mazzoccoli, Carmela; Da Pozzo, Eleonora; Cavallini, Chiara; Martini, Claudia; Orlando, Viviana; Biagioni, Stefano; Mazzoni, Cristina; Coluccia, Addolorata Maria Luce; Hamel, Ernest; Liu, Te; Silvestri, Romano; La Regina, Giuseppe.

In: European Journal of Medicinal Chemistry, 02.11.2019, p. 111828.

Research output: Contribution to journalArticle

Puxeddu, M, Shen, H, Bai, R, Coluccia, A, Nalli, M, Mazzoccoli, C, Da Pozzo, E, Cavallini, C, Martini, C, Orlando, V, Biagioni, S, Mazzoni, C, Coluccia, AML, Hamel, E, Liu, T, Silvestri, R & La Regina, G 2019, 'Structure-activity relationship studies and in vitro and in vivo anticancer activity of novel 3-aroyl-1,4-diarylpyrroles against solid tumors and hematological malignancies', European Journal of Medicinal Chemistry, pp. 111828. https://doi.org/10.1016/j.ejmech.2019.111828
Puxeddu, Michela ; Shen, Hongliang ; Bai, Ruoli ; Coluccia, Antonio ; Nalli, Marianna ; Mazzoccoli, Carmela ; Da Pozzo, Eleonora ; Cavallini, Chiara ; Martini, Claudia ; Orlando, Viviana ; Biagioni, Stefano ; Mazzoni, Cristina ; Coluccia, Addolorata Maria Luce ; Hamel, Ernest ; Liu, Te ; Silvestri, Romano ; La Regina, Giuseppe. / Structure-activity relationship studies and in vitro and in vivo anticancer activity of novel 3-aroyl-1,4-diarylpyrroles against solid tumors and hematological malignancies. In: European Journal of Medicinal Chemistry. 2019 ; pp. 111828.
@article{8da36df27265454b9c4ec64c9804fff9,
title = "Structure-activity relationship studies and in vitro and in vivo anticancer activity of novel 3-aroyl-1,4-diarylpyrroles against solid tumors and hematological malignancies",
abstract = "Novel 3-aroyl-1,4-diarylpyrrole derivatives were synthesized to explore structure-activity relationships at the phenyls at positions 1 and 4 of the pyrrole. The presence of amino phenyl rings at positions 1 and 4 of the pyrrole ring were found to be a crucial requirement for potent antitumor activity. Several compounds strongly inhibited tubulin assembly through binding to the colchicine site. Compounds 42, 44, 48, 62 and 69 showed antitumor activity with low nanomolar IC50 values in several cancer cell lines. Compound 48 was generally more effective as an inhibitor of glioblastoma, colorectal and urinary bladder cancer cell lines; 69 consistently inhibited CML cell lines and demonstrated superiority in nilotinib and imatinib resistant LAMA84-R and KBM5-T315I cells. In animal models, compound 48 exhibited significant inhibition of the growth of T24 bladder carcinoma and ES-2 ovarian clear cell carcinoma tumors. Compounds 48 and 69 represent robust lead compounds for the design of new broad-spectrum anticancer agents active in different types of solid and hematological tumors.",
author = "Michela Puxeddu and Hongliang Shen and Ruoli Bai and Antonio Coluccia and Marianna Nalli and Carmela Mazzoccoli and {Da Pozzo}, Eleonora and Chiara Cavallini and Claudia Martini and Viviana Orlando and Stefano Biagioni and Cristina Mazzoni and Coluccia, {Addolorata Maria Luce} and Ernest Hamel and Te Liu and Romano Silvestri and {La Regina}, Giuseppe",
note = "Copyright {\circledC} 2019 Elsevier Masson SAS. All rights reserved.",
year = "2019",
month = "11",
day = "2",
doi = "10.1016/j.ejmech.2019.111828",
language = "English",
pages = "111828",
journal = "European Journal of Medicinal Chemistry",
issn = "0223-5234",
publisher = "Elsevier Masson SAS",

}

TY - JOUR

T1 - Structure-activity relationship studies and in vitro and in vivo anticancer activity of novel 3-aroyl-1,4-diarylpyrroles against solid tumors and hematological malignancies

AU - Puxeddu, Michela

AU - Shen, Hongliang

AU - Bai, Ruoli

AU - Coluccia, Antonio

AU - Nalli, Marianna

AU - Mazzoccoli, Carmela

AU - Da Pozzo, Eleonora

AU - Cavallini, Chiara

AU - Martini, Claudia

AU - Orlando, Viviana

AU - Biagioni, Stefano

AU - Mazzoni, Cristina

AU - Coluccia, Addolorata Maria Luce

AU - Hamel, Ernest

AU - Liu, Te

AU - Silvestri, Romano

AU - La Regina, Giuseppe

N1 - Copyright © 2019 Elsevier Masson SAS. All rights reserved.

PY - 2019/11/2

Y1 - 2019/11/2

N2 - Novel 3-aroyl-1,4-diarylpyrrole derivatives were synthesized to explore structure-activity relationships at the phenyls at positions 1 and 4 of the pyrrole. The presence of amino phenyl rings at positions 1 and 4 of the pyrrole ring were found to be a crucial requirement for potent antitumor activity. Several compounds strongly inhibited tubulin assembly through binding to the colchicine site. Compounds 42, 44, 48, 62 and 69 showed antitumor activity with low nanomolar IC50 values in several cancer cell lines. Compound 48 was generally more effective as an inhibitor of glioblastoma, colorectal and urinary bladder cancer cell lines; 69 consistently inhibited CML cell lines and demonstrated superiority in nilotinib and imatinib resistant LAMA84-R and KBM5-T315I cells. In animal models, compound 48 exhibited significant inhibition of the growth of T24 bladder carcinoma and ES-2 ovarian clear cell carcinoma tumors. Compounds 48 and 69 represent robust lead compounds for the design of new broad-spectrum anticancer agents active in different types of solid and hematological tumors.

AB - Novel 3-aroyl-1,4-diarylpyrrole derivatives were synthesized to explore structure-activity relationships at the phenyls at positions 1 and 4 of the pyrrole. The presence of amino phenyl rings at positions 1 and 4 of the pyrrole ring were found to be a crucial requirement for potent antitumor activity. Several compounds strongly inhibited tubulin assembly through binding to the colchicine site. Compounds 42, 44, 48, 62 and 69 showed antitumor activity with low nanomolar IC50 values in several cancer cell lines. Compound 48 was generally more effective as an inhibitor of glioblastoma, colorectal and urinary bladder cancer cell lines; 69 consistently inhibited CML cell lines and demonstrated superiority in nilotinib and imatinib resistant LAMA84-R and KBM5-T315I cells. In animal models, compound 48 exhibited significant inhibition of the growth of T24 bladder carcinoma and ES-2 ovarian clear cell carcinoma tumors. Compounds 48 and 69 represent robust lead compounds for the design of new broad-spectrum anticancer agents active in different types of solid and hematological tumors.

U2 - 10.1016/j.ejmech.2019.111828

DO - 10.1016/j.ejmech.2019.111828

M3 - Article

C2 - 31727471

SP - 111828

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

SN - 0223-5234

ER -